SoulMedX
Oral Drug Dosage Precision
Health Tech & Life Sciences
Non Active, Jan 2025 ceased to operate
Company Overview
Snapshot
Founded in July 2018 by Eran Katz and Dr. Moshe Brand, SoulMedX operates with 1–10 employees. The company ceased operations in January 2025.
Business overview
SoulMedX developed an AI-powered system for precise dosage personalization of oral drugs, designed for at-home use. Combining artificial intelligence, big data, and flexible dispensing technologies, the company's solution enabled remote adjustment of dosage based on patient behavior. SoulMedX operated within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Engagement, targeting patients within the healthcare industry.
Company Intelligence Q&A
- What is SoulMedX's primary focus?
- SoulMedX focused on oral drug dosage precision, utilizing artificial intelligence and big data to enable personalized medication delivery at patients' homes.
- When was SoulMedX founded?
- SoulMedX was founded in July 2018.
- Who are the founders of SoulMedX?
- SoulMedX was founded by Eran Katz and Dr. Moshe Brand.
- What is the operational status of SoulMedX?
- SoulMedX is currently non-active and ceased to operate in January 2025.
- What technology did SoulMedX utilize in its solution?
- SoulMedX combined artificial intelligence, big data, and flexible dispensing technologies to enable remote adjustment of oral drug dosages.